Global Metabolic Disorder Therapeutics Market Size, Competitive Analysis, Share, Forecast- 2020-2026

1. Orion Market Research Global Metabolic Disorder Therapeutics Market Size, Competitive Analysis, Share, Forecast- 2020-2026 Request a Free Sample @ https://www.omrglobal.com/request-sample/metabolic-disorder- therapeutics-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

2. The global metabolic disorder therapeutics market is estimated to grow at a CAGR of 7.8% during the forecast period. An increasing number of clinical trials have been witnessed over the years owing to the rising prevalence of metabolic disorders and increasing demand for more effective treatment. For instance, in May 2020, POXEL SA, a biopharmaceutical company focused to develop innovative treatments for metabolic disorders, such as non-alcoholic steatohepatitis (NASH) and type 2 diabetes declared new preclinical results for PXL770. It is a direct adenosine monophosphate-activated protein kinase(AMPK) activator, was assessed in a rodent NASH model along with other major agents in development, such as a thyroid receptor ? agonist (MGL-3196), an FXR agonist (obeticholic acid), and a GLP-1 receptor agonist (semaglutide). To @ https://www.omrglobal.com/request-sample/metabolic-disorder-therapeutics-market learn more about this report request a free sample copy The outcomes feature PXL770 as a potential new NASH therapy that may develop complementary advantages while combined with other agents with different action mechanisms. Further, in September 2020, Kaleido Biosciences, Inc. declared that it has evaluated Microbiome Metabolic Therapy (MMT) candidate KB295 in the first patient suffering from mild-to-moderate ulcerative colitis. Such kinds of clinical studies are offering an opportunity for new launches of innovative therapies for metabolic disorders, which in turn, will further accelerate the market growth. Browse reports/metabolic-disorder-therapeutics-market for Full Report Description@ https://www.omrglobal.com/industry- Global Metabolic Disorder Therapeutics Market-Segmentation By Therapy Drug Therapy Gene Therapy Cellular Transplantation Enzyme Replacement Therapy Others By Disease Obesity Diabetes Lysosomal Storage Disease Hypercholesterolemia Others Global Metabolic Disorder Therapeutics Market– Segment by Region

3. North America United States Canada Europe UK Germany Italy Spain France Rest of Europe Asia-Pacific China India Japan Rest of Asia-Pacific Rest of the World Latin America The Middle East and Africa Company Profiles AbbVie, Inc. Actelion Pharmaceuticals, Ltd. Agios Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Amgen, Inc. AstraZeneca plc Biocon, Ltd. BioMarin Pharmaceutical, Inc. Boehringer Ingelheim GmbH Bristol-Myers Squibb Co. Cipla, Inc.

4. CymaBay Therapeutics, Inc. Dracen Pharmaceuticals, Inc. Eli Lilly and Co. Intra-Cellular Therapies, Inc. Merck KGaA Novo Nordisk A/S Orchard Therapeutics plc Pfizer, Inc. Sanofi S.A. Shire Pharmaceuticals Group plc Sigilon Therapeutics, Inc. Silence Therapeutics For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/metabolic-disorder-therapeutics-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404